Exogenesis Corporation is a privately-held, venture capital backed company developing and commercializing proprietary nanoscale surface modification and surface control technologies which have application in improving the safety and efficacy of implantable medical devices and improving the performance of optics, glass and a variety of substrates used in the laser, memory and semiconductor industries.
The Exogenesis technology has the unique ability to produce important atomic level surface modification effects without coatings or additives.
The NanoAccelTM Gas Cluster Ion Beam (GCIB) technology was originally developed to provide nanoscale surface processing of semiconductors and other opto-electronic devices. Exogenesis acquired the exclusive worldwide rights to GCIB intellectual property for biomedical applications and has subsequently developed a complementary particle beam processing technology called NanoAccel Accelerated Neutral Atom Beam (ANAB).
Exogenesis is engaged in development activities with a number of partners and is interested in exploring new applications for its technology in biomedical and non-medical applications with partners interested in improving the properties and performance of materials.
Exogenesis is seeking partners in collaborative research and commercialization
of its proprietary nanoscale surface modification technology.
Click here to read more about our Platform Technology.
Click here to read about our Biomedical Applications.
Click here to read about our Industrial Optics and Semiconductor Applications.